The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next two to three months.

Tirzepatide is the active ingredient in Eli ... "The drugs they are advertising are not yet available in quantities to meet demand. Until they are, state-licensed pharmacies will continue to ...

All have been reported as "available" by their respective manufacturers ... monitor supply and demand for these products, including tirzepatide.

Compounded tirzepatide is often cheaper than FDA-approved versions, making it much more accessible. It’s more widely available. As there are often shortages of tirzepatide, you might find ...

On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a declaratory order determining that the shortage of diabetes and ...

Risk for pancreatitis was not elevated among users of tirzepatide relative to placebo, despite the presence of elevated pancreatic enzymes.

Ready to crush your New Year’s health goals? These breakthrough medications offer more than weight loss—they support your ...

Eli Lilly (LLY) stock fell as its obesity therapy tirzepatide missed forecasts, amid focus on compounded weight loss ...

Eli Lilly joins FDA lawsuit over tirzepatide shortage listing, as Outsourcing Facilities Association challenges removal of ...

New findings on semaglutide and tirzepatide published in 2024 revealed that the medications may have benefits beyond lowering ...

Cost and availability: Tirzepatide is newer to the market and may be less widely available or more expensive than semaglutide. Side effects: Both medications share common side effects like nausea ...